Subcuteous Methotrexate in Rheumatoid Arthritis

Clinical trial NCT07094880 · COMPLETED

Trial details

NCT number: NCT07094880
Sponsor: Bangladesh Medical University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Methotrexate Adverse Reaction Advantage of Using Subcutaneous Route for Methotrexate

Start date: 2015-06-01
Primary completion: 2016-06-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.